Candesartan-induced gene expression in five organs of stroke-prone spontaneously hypertensive rats

Hypertension Research

Volumn 31, Issue 10, 2008, Pages 1963-1975

  Kato, Norihiro ^a   Liang, Yi Qiang ^a   Ochiai, Yoshinori ^a   Birukawa, Naoko ^a   Serizawa, Masakuni ^a   Jesmin, Subrina ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; HYDRALAZINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CYTOLOGY; DNA MICROARRAY; ESSENTIAL HYPERTENSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; HEART; HEART VENTRICLE HYPERTROPHY; IMMEDIATE EARLY GENE; INTERMETHOD COMPARISON; KIDNEY; LIVER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTECTION; RAT; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TISSUE SPECIFICITY; UNINDEXED SEQUENCE; WISTAR KYOTO RAT; ANIMAL; ANTIBODY SPECIFICITY; DRUG EFFECT; GENETICS; HYPERTENSION; PHYSIOLOGY; REPRODUCIBILITY; SPECIES DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; STANDARD; STROKE;

ADIPOSE TISSUE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BRAIN; GENE EXPRESSION REGULATION; HEART; HYDRALAZINE; HYPERTENSION; KIDNEY; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; STROKE; TETRAZOLES;

EID: 58149387667     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1963     Document Type: Article

References (31)

1. Danser AH: Local renin-angiTtensin systems: the unanswered questions. Int J Biochem Cell Biol 2003; 35: 759-768.
2. Kobori H, Nangaku M, Navar LG, Nishiyama A: The intra-renal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-287.
3. Chrysant SG: The pathophysiologic role of the brain renin-angiotensin system in stroke protection: Clinical implications. J Clin Hypertens 2007; 9: 454-459.
4. Bader M: Role of the local renin-angiotensin system in cArdiac damage: a minireview focussing on transgenic animal models. J Mol Cell Cardiol 2002; 34: 1455-1462.
5. Paul M, Poyan Mehr A, Kreutz R: Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747-803.
6. Ferreira JC, Bacurau AV, Evangelista FS, et al: The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Am J Physiol Regul Integr Comp Physiol 2008; 294: R26-R32.
7. Zhou J, Pavel J, Macova M, et al: AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke 2006; 37: 1271-1276.
8. Dzau V: The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J Hyprertens Suppl 2005; 23: S9-S17.
9. Kato N, Mashimo T, Nabika T, Cui ZH, Ikeda K, Yamori Y: Genome-wide searches for blood pressure quantitative trait loci in the stroke-prone spontaneously hypertensive rat of a Japanese colony. J Hypertens 2003; 21: 295-303.
10. Hamaya Y, Takeda T, Dohi S, Nakashima S, Nozawa Y: The effects of pentobarbital, isoflurane, and propofol on immediate-early gene expression in the vital organs of the rat. Anesth Analg 2000; 90: 1177-1183.
11. Hu J, Gray CA, Spencer TE: Gene expression profiling of neonatal mouse uterine development. Biol Reprod 2004; 70: 1870-1876.
12. Davidson L.A, Nguyen DV, Hokanson RM, et al. Chemopreventive n 3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res 2004; 64: 6796-6804.
13. Ramakrishnan R, Dorri D, Lublinsky A, et al: An assessment of Motorolo CodeLink microarray performance for gene expression profiling applications. Nucleic Acids Res 2002; 30: E30.
14. Treister NS, Richards SM, Suzuki T, Jensen RV, Sullivan DA: Influence of androgens on gene expression in the BALB/c mouse submandibular gland. J Dent Res 2005; 84: 1187-1192.
15. Kato N, Liang YQ, Ochiai Y, Jesmin S: Systemic evaluation of gene expression changes in major target organs induced by atorvastatin. Eur J Pharmacol 2008; 584: 376-389.
16. AshburnerTM, Ball CA, Blake JA, et al: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29.
17. Hwang DM, Dempsey AA, Wang RX, et al: A genome-based resource for molecular cardiovascular medicine: Toward a compendium of cardiovascular genes. Circulation 1997; 96: 4146-4203.
18. Varagic J, Frohlich ED: Local cardiac renin-angiotensin system: hypertension and cardiac failure. J Mol Cell Cardiol 2002; 34 1435-1442.
19. Dendorfer A, Dominiak P, Schunkert H: ACE inhibitors and angiotensin II receptor antagonists. Handb Exp Pharmacol 2005; 170: 407-442.
20. Takai S, Kirimura K, Jin D, et al: Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling. Hypertens Res 2005; 28: 593-600.
21. Yamamoto K, Mano T, Yoshida J, et al: ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure. J Hypertens 2005; 23: 393-400.
22. Kim S, Yoshiyama M, Izumi Y, et al: Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure. Circulation 2001; 103: 148-154.
23. Ito T, Yamakawa H, Bregonzio C, Terrón JA, Falcón-Neri A, Saavedra JM: Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 2002; 33: 2297-2303.
24. Zhou J, Jezova M, Elkahloun AG, Saavedra JM: Angiotensin II AT1 receptor antagonism downregulates stress-related gene expression in brain microvessels from spontaneously hypertensive and normotensive rats. Ann N Y Acad Sci 2004; 1018: 480-486.
25. Lu Q, Zhu YZ, Wong PT: Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats. Neuroreport 2005; 16: 1963-1967.
26. Collison M, Glazier AM, Graham D, et al: Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes 2000; 49: 2222-2226.
27. Kim S, Soltani-Bejnood M, Quignard-Boulange A, et al: The adipose renin-angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal renin-angiotensin system. J Biomed Biotechnol 2006; 2006: 27012.
28. Sharma AM, Engeli S: The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome. J Cardiometab Syndr 2006; 1: 29-35.
29. Staessen JA, Li Y, Thijs L, Wang JG: Blood pressure reduction and cardiovascular prevention: An update including the 2003-2004 secondary prevention trials. Hypertens Res 2005; 28: 385-407.
30. Lazartigues E, Feng Y, Lavoie JL: The two fACEs of the tissue renin-angiotensin systems: Implication in cardiovascular diseases. Curr Pharm Des 2007; 13: 1231-1245.
31. Engeli S, Schling P, Gorzelniak K, et al: The adipose-tissue renin-angiotensin-aldosterone system: Role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35: 807-825.